Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

An Exploratory Pilot Study of Palliadelic Treatment to Reduce Psychological Distress and Improve Quality of Life in Persons With Pancreatobiliary Cancer, With a Parallel Assessment of Healthcare Utilization and Family Wellbeing

To see complete record on, please visit this link

Id: NCT05220046

Organisation Name: University of Nebraska

Overal Status: Not yet recruiting

Start Date: September 2022

Last Update: June 22, 2022

Lead Sponsor: Lou Lukas

Brief Summary: The primary objective of this study is to evaluate the ability to recruit and retain participants, and to successfully conduct a psilocybin-based protocol, for a study of the treatment of distress related to inoperable pancreatobilliary cancer. Secondary objectives include pre/post, and longitudinal measurement of distress in intervention participants and a paired family member who is in an observational arm.

  • Pancreas Cancer
  • Biliary Tract Cancer
  • Psychological Distress

Total execution time in seconds: 0.31160593032837